BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 10931807)

  • 1. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene.
    Kokado H; Shimizu M; Yoshio H; Ino H; Okeie K; Emoto Y; Matsuyama T; Yamaguchi M; Yasuda T; Fujino N; Ito H; Mabuchi H
    Circulation; 2000 Aug; 102(6):663-9. PubMed ID: 10931807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.
    Doolan A; Tebo M; Ingles J; Nguyen L; Tsoutsman T; Lam L; Chiu C; Chung J; Weintraub RG; Semsarian C
    J Mol Cell Cardiol; 2005 Feb; 38(2):387-93. PubMed ID: 15698845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
    Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.
    Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R
    J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients.
    Konno T; Shimizu M; Ino H; Matsuyama T; Yamaguchi M; Terai H; Hayashi K; Mabuchi T; Kiyama M; Sakata K; Hayashi T; Inoue M; Kaneda T; Mabuchi H
    J Am Coll Cardiol; 2003 Mar; 41(5):781-6. PubMed ID: 12628722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion.
    Shimizu M; Ino H; Okeie K; Yamaguchi M; Nagata M; Hayashi K; Itoh H; Iwaki T; Oe K; Konno T; Mabuchi H
    Clin Cardiol; 2002 Jul; 25(7):335-9. PubMed ID: 12109867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life.
    Calore C; De Bortoli M; Romualdi C; Lorenzon A; Angelini A; Basso C; Thiene G; Iliceto S; Rampazzo A; Melacini P
    J Med Genet; 2015 May; 52(5):338-47. PubMed ID: 25740977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic Cardiomyopathy.
    Fahed AC; Nemer G; Bitar FF; Arnaout S; Abchee AB; Batrawi M; Khalil A; Abou Hassan OK; DePalma SR; McDonough B; Arabi MT; Ware JS; Seidman JG; Seidman CE
    Circ Genom Precis Med; 2020 Oct; 13(5):444-452. PubMed ID: 32885985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in the cardiac myosin-binding protein C gene is responsible for hypertrophic cardiomyopathy with severe ventricular hypertrophy and sudden death.
    Konno T; Shimizu M; Ino H; Fujino N; Uchiyama K; Mabuchi T; Sakata K; Kaneda T; Fujita T; Masuta E; Mabuchi H
    Clin Sci (Lond); 2006 Jan; 110(1):125-31. PubMed ID: 16181148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.
    Epstein ND; Cohn GM; Cyran F; Fananapazir L
    Circulation; 1992 Aug; 86(2):345-52. PubMed ID: 1638703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronologic electrocardiographic changes in patients with hypertrophic cardiomyopathy associated with cardiac troponin 1 mutation.
    Shimizu M; Ino H; Yamaguchi M; Terai H; Hayashi K; Kiyama M; Sakata K; Hayashi T; Inoue M; Kaneda T; Mabuchi H
    Am Heart J; 2002 Feb; 143(2):289-93. PubMed ID: 11835033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy.
    Kimura A; Harada H; Park JE; Nishi H; Satoh M; Takahashi M; Hiroi S; Sasaoka T; Ohbuchi N; Nakamura T; Koyanagi T; Hwang TH; Choo JA; Chung KS; Hasegawa A; Nagai R; Okazaki O; Nakamura H; Matsuzaki M; Sakamoto T; Toshima H; Koga Y; Imaizumi T; Sasazuki T
    Nat Genet; 1997 Aug; 16(4):379-82. PubMed ID: 9241277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations.
    Marian AJ; Mares A; Kelly DP; Yu QT; Abchee AB; Hill R; Roberts R
    Eur Heart J; 1995 Mar; 16(3):368-76. PubMed ID: 7789380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy.
    Forissier JF; Carrier L; Farza H; Bonne G; Bercovici J; Richard P; Hainque B; Townsend PJ; Yacoub MH; Fauré S; Dubourg O; Millaire A; Hagège AA; Desnos M; Komajda M; Schwartz K
    Circulation; 1996 Dec; 94(12):3069-73. PubMed ID: 8989109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac beta myosin heavy chain gene mutations.
    Posen BM; Moolman JC; Corfield VA; Brink PA
    Br Heart J; 1995 Jul; 74(1):40-6. PubMed ID: 7662452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy.
    Curila K; Benesova L; Penicka M; Minarik M; Zemanek D; Veselka J; Widimsky P; Gregor P
    Genet Test Mol Biomarkers; 2009 Oct; 13(5):647-50. PubMed ID: 19645627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Prognostic Profiles of Cardiomyopathies Caused by Mutations in the Troponin T Gene.
    Ripoll-Vera T; Gámez JM; Govea N; Gómez Y; Núñez J; Socías L; Escandell Á; Rosell J
    Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):149-58. PubMed ID: 26507537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allele and species dependent contractile defects by restrictive and hypertrophic cardiomyopathy-linked troponin I mutants.
    Davis J; Wen H; Edwards T; Metzger JM
    J Mol Cell Cardiol; 2008 May; 44(5):891-904. PubMed ID: 18423659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden death due to troponin T mutations.
    Moolman JC; Corfield VA; Posen B; Ngumbela K; Seidman C; Brink PA; Watkins H
    J Am Coll Cardiol; 1997 Mar; 29(3):549-55. PubMed ID: 9060892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.